These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9231320)

  • 21. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
    Saetre E; Perucca E; Isojärvi J; Gjerstad L;
    Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolution of self-injury with phenytoin in a man with autism and intellectual disability: the role of frontal lobe seizures and catatonia.
    Coffey MJ
    J ECT; 2013 Mar; 29(1):e12-3. PubMed ID: 23422527
    [No Abstract]   [Full Text] [Related]  

  • 24. Lamotrigine in patients with epilepsy and comorbid depressive symptoms.
    Fakhoury TA; Barry JJ; Mitchell Miller J; Hammer AE; Vuong A
    Epilepsy Behav; 2007 Feb; 10(1):155-62. PubMed ID: 17166775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-injury in people with intellectual disability and epilepsy: a matched controlled study.
    Buono S; Scannella F; Palmigiano MB; Elia M; Kerr M; Di Nuovo S
    Seizure; 2012 Apr; 21(3):160-4. PubMed ID: 22244737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA; García VF; Astencio AG; Cuartas VB
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
    Sajatovic M; Ramsay E; Nanry K; Thompson T
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):945-50. PubMed ID: 17326238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-release lamotrigine in the treatment of patients with epilepsy.
    Syed TU; Sajatovic M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1579-85. PubMed ID: 20482306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
    EURAP Study Group
    Neurology; 2006 Feb; 66(3):354-60. PubMed ID: 16382034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
    Thome-Souza S; Valente KD
    Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities.
    Garber HJ; McGonigle JJ; Slomka GT; Monteverde E
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1157-60. PubMed ID: 1429420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
    Biton V; Di Memmo J; Shukla R; Lee YY; Poverennova I; Demchenko V; Saiers J; Adams B; Hammer A; Vuong A; Messenheimer J
    Epilepsy Behav; 2010 Nov; 19(3):352-8. PubMed ID: 20937567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy.
    Eun SH; Eun BL; Lee JS; Hwang YS; Kim KJ; Lee YM; Lee IG; Lee M; Ko TS; Kim JT; Eom S; Kim HD
    Brain Dev; 2012 Nov; 34(10):818-23. PubMed ID: 22521904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
    Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
    Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of lamotrigine in medically intractable epilepsies in children.
    Zubcevic S; Cengic A; Catibusic F; Uzicanin S
    Med Arh; 2008; 62(3):162-4. PubMed ID: 18822946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.